Cargando…
Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting
The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored the Translational Advances in Cancer Prevention Agent Development Meeting on August 27 to 28, 2020. The goals of this meeting were to foster...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Cancer Prevention
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020174/ https://www.ncbi.nlm.nih.gov/pubmed/33842408 http://dx.doi.org/10.15430/JCP.2021.26.1.71 |
| _version_ | 1783674531379937280 |
|---|---|
| author | Miller, Mark Steven Allen, Peter J. Brown, Powel H. Chan, Andrew T. Clapper, Margie L. Dashwood, Roderick H. Demehri, Shadmehr Disis, Mary L. DuBois, Raymond N. Glynn, Robert J. Kensler, Thomas W. Khan, Seema A. Johnson, Bryon D. Liby, Karen T. Lipkin, Steven M. Mallery, Susan R. Meuillet, Emmanuelle J. Roden, Richard B.S. Schoen, Robert E. Sharp, Zelton D. Shirwan, Haval Siegfried, Jill M. Rao, Chinthalapally V. You, Ming Vilar, Eduardo Szabo, Eva Mohammed, Altaf |
| author_facet | Miller, Mark Steven Allen, Peter J. Brown, Powel H. Chan, Andrew T. Clapper, Margie L. Dashwood, Roderick H. Demehri, Shadmehr Disis, Mary L. DuBois, Raymond N. Glynn, Robert J. Kensler, Thomas W. Khan, Seema A. Johnson, Bryon D. Liby, Karen T. Lipkin, Steven M. Mallery, Susan R. Meuillet, Emmanuelle J. Roden, Richard B.S. Schoen, Robert E. Sharp, Zelton D. Shirwan, Haval Siegfried, Jill M. Rao, Chinthalapally V. You, Ming Vilar, Eduardo Szabo, Eva Mohammed, Altaf |
| author_sort | Miller, Mark Steven |
| collection | PubMed |
| description | The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored the Translational Advances in Cancer Prevention Agent Development Meeting on August 27 to 28, 2020. The goals of this meeting were to foster the exchange of ideas and stimulate new collaborative interactions among leading cancer prevention researchers from basic and clinical research; highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials; and provide information to the extramural research community on the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials. The meeting included two plenary talks and five sessions covering the range from pre-clinical studies with chemo/immunopreventive agents to ongoing cancer prevention clinical trials. In addition, two NCI informational sessions describing contract resources for the preclinical agent development and cooperative grants for the Cancer Prevention Clinical Trials Network were also presented. |
| format | Online Article Text |
| id | pubmed-8020174 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Korean Society of Cancer Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80201742021-04-09 Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting Miller, Mark Steven Allen, Peter J. Brown, Powel H. Chan, Andrew T. Clapper, Margie L. Dashwood, Roderick H. Demehri, Shadmehr Disis, Mary L. DuBois, Raymond N. Glynn, Robert J. Kensler, Thomas W. Khan, Seema A. Johnson, Bryon D. Liby, Karen T. Lipkin, Steven M. Mallery, Susan R. Meuillet, Emmanuelle J. Roden, Richard B.S. Schoen, Robert E. Sharp, Zelton D. Shirwan, Haval Siegfried, Jill M. Rao, Chinthalapally V. You, Ming Vilar, Eduardo Szabo, Eva Mohammed, Altaf J Cancer Prev Meeting Report The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored the Translational Advances in Cancer Prevention Agent Development Meeting on August 27 to 28, 2020. The goals of this meeting were to foster the exchange of ideas and stimulate new collaborative interactions among leading cancer prevention researchers from basic and clinical research; highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials; and provide information to the extramural research community on the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials. The meeting included two plenary talks and five sessions covering the range from pre-clinical studies with chemo/immunopreventive agents to ongoing cancer prevention clinical trials. In addition, two NCI informational sessions describing contract resources for the preclinical agent development and cooperative grants for the Cancer Prevention Clinical Trials Network were also presented. Korean Society of Cancer Prevention 2021-03-30 2021-03-30 /pmc/articles/PMC8020174/ /pubmed/33842408 http://dx.doi.org/10.15430/JCP.2021.26.1.71 Text en Copyright © 2021 Korean Society of Cancer Prevention This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Meeting Report Miller, Mark Steven Allen, Peter J. Brown, Powel H. Chan, Andrew T. Clapper, Margie L. Dashwood, Roderick H. Demehri, Shadmehr Disis, Mary L. DuBois, Raymond N. Glynn, Robert J. Kensler, Thomas W. Khan, Seema A. Johnson, Bryon D. Liby, Karen T. Lipkin, Steven M. Mallery, Susan R. Meuillet, Emmanuelle J. Roden, Richard B.S. Schoen, Robert E. Sharp, Zelton D. Shirwan, Haval Siegfried, Jill M. Rao, Chinthalapally V. You, Ming Vilar, Eduardo Szabo, Eva Mohammed, Altaf Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting |
| title | Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting |
| title_full | Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting |
| title_fullStr | Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting |
| title_full_unstemmed | Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting |
| title_short | Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting |
| title_sort | meeting report: translational advances in cancer prevention agent development meeting |
| topic | Meeting Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020174/ https://www.ncbi.nlm.nih.gov/pubmed/33842408 http://dx.doi.org/10.15430/JCP.2021.26.1.71 |
| work_keys_str_mv | AT millermarksteven meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT allenpeterj meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT brownpowelh meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT chanandrewt meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT clappermargiel meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT dashwoodroderickh meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT demehrishadmehr meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT disismaryl meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT duboisraymondn meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT glynnrobertj meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT kenslerthomasw meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT khanseemaa meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT johnsonbryond meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT libykarent meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT lipkinstevenm meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT mallerysusanr meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT meuilletemmanuellej meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT rodenrichardbs meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT schoenroberte meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT sharpzeltond meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT shirwanhaval meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT siegfriedjillm meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT raochinthalapallyv meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT youming meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT vilareduardo meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT szaboeva meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting AT mohammedaltaf meetingreporttranslationaladvancesincancerpreventionagentdevelopmentmeeting |